CAN
Cann Group Ltd
Director Trades
| Date | Director | Value |
|---|---|---|
| J. Chick | $3,333 | |
| D. Rathbone | $2,400 | |
| R. Barnes | $2,667 | |
| J. Pilcher | $4,407 |
Company News
Trump’s CBD Comments Ignite US Cannabis Stocks Surge – Will ASX Companies Follow Suit?
Shares of cannabis and CBD-related companies surged on Monday after US President Donald Trump posted on Truth Social that hemp-derived cannabidiol (CBD), especially in senior healthcare, “could revolutionize” treatment by reducing disease progression and providing an alternative to prescription drugs. He further reiterated his administration is exploring reclassifying marijuana under federal law, a change that could […]
Cann to supply medicinal cannabis products to EU and UK, IDT will manufacture
Australian cannabis developer Cann Group (ASX: CAN) has signed two agreements for the supply of medicinal cannabis-formulated oil and dried flower products to markets in the United Kingdom and European Union. The first deal is with UK-based Astral Health for the supply of oils including high THC (tetrahydrocannabinol), high CBD (cannabidiol) and a balanced formulation […]
Cann Group and IDT Australia move closer to bringing medicinal cannabis products to market
Cann Group (ASX: CAN) and IDT Australia (ASX: IDT) are closer to producing their first medicinal cannabis products with GMP extraction activities now underway. Once extracted, the resin will be used as an active pharmaceutical ingredient for either purchase or to produce GMP medicinal cannabis oil products at IDT’s facilities. The next step for the […]
Cann Group and IDT Australia prepare for commercial launch of medicinal cannabis product
Cann Group (ASX: CAN) has confirmed the first commercial medicinal cannabis product to be made at Cann’s Australian-based cultivation operations has been packed by IDT Australia (ASX: IDT) in preparation for commercial release in the new year. Medicinal cannabis dried flower has now been packed into 10 gram bottles by IDT and will undergo stability […]
Cann Group picks up manufacturing licences for existing facilities
One of Australia’s leading cannabis developers, Cann Group (ASX: CAN) has been approved to manufacture cannabis products at its existing northern and southern medicinal cannabis facilities in Melbourne. The licences relate to the manufacturing, packaging, storage, transport and disposal of medicinal cannabis in final dose and intermediate forms. However, the company must still obtain appropriate […]
Cann Group grows medicinal cannabis cultivation capacity, locks-in offtake agreement
Under a new agreement, Cann Group (ASX: CAN) will construct a state-of-the-art large-scale greenhouse in north-west Victoria’s Mildura’s region to produce medicinal cannabis for domestic and international markets. The company has signed a non-binding heads of agreement to purchase the site for $10.75 million (plus GST) and expects produce about 50,000 kilograms of dry cannabis […]
Cann Group nets government tender to supply cannabis resin for children with epilepsy
Cann Group (ASX: CAN) has secured a deal with the Victorian government to supply cannabis plant extract, or resin, to be used to treat children with severe or intractable epilepsy. The medicinal cannabis developer today announced it had been awarded the tender with the Office of Medicinal Cannabis, under the state’s Department of Health and […]
Australian pot stocks cultivating commercial progress in Canada
The onset of softening legislation towards cannabis in Canada and in other jurisdictions such as the US and Australia – both medicinally and recreationally – is providing a series of commercial opportunities for ASX-listed pot stock hopefuls such as Creso Pharma (ASX: CPH) and MMJ (ASX: MMJ). Both companies announced commercially encouraging news regarding their […]
Cann Group completes first harvest of medicinal cannabis
Melbourne-based Cann Group (ASX: CAN) reports that it has completed harvest of its first cultivation cycle of medicinal cannabis at its Southern facility in Victoria. The production process, which includes the curing and drying of harvested material, has been completed, and approval was received from the Office of Drug Control (ODC) late on Friday 25 […]
‘Pot stock’ Cann Group gets green light to expand its two Victorian facilities
Medicinal cannabis developer Cann Group (ASX: CAN) has secured regulatory approvals to boost capacity at its two Victorian facilities in Australia. Australia’s Office of Drug Control has approved Cann’s request to vary its existing medicinal cannabis and cannabis research licences to use the expanded capacity at its Southern Victoria facility and to increase its cultivation, […]
Company Videos
No videos found.